( NASDAQ-SMALL:NTEC )

News from Intec Pharma Ltd A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Nov 15, 2017, 16:01 ET Intec Pharma Reports Third Quarter 2017 Operating and Financial Results

Intec Pharma LTD (NASDAQ: NTEC) (TASE: NTEC) today announced its third quarter 2017 financial results and provided a corporate update. "The third...


Nov 08, 2017, 08:00 ET Intec Pharma, Ltd. to Present at the Jefferies 2017 London Healthcare Conference

Intec Pharma Ltd. (NASDAQ, TASE: NTEC), a clinical stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion...


Nov 01, 2017, 07:00 ET Intec Pharma, Ltd. Announces Changes to its Board of Directors

Intec Pharma Ltd. (NASDAQ, TASE: NTEC), a clinical stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion...


Nov 01, 2017, 07:00 ET Intec Pharma Ltd. Announces Changes to its Board of Directors

Intec Pharma Ltd. (Nasdaq, TASE: NTEC), a clinical stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion...


Oct 26, 2017, 07:00 ET Intec Pharma Names Walt Linscott as Chief Administrative Officer

Intec Pharma Ltd. (Nasdaq: NTEC) (TASE: NTEC), a clinical-stage biopharmaceutical company focused on developing drugs based on its proprietary...


Oct 06, 2017, 07:00 ET Intec Pharma to Participate in the Oppenheimer Specialty Pharma Summit

Intec Pharma Ltd. (NASDAQ and TASE: NTEC) today announced that management will participate in the Oppenheimer Specialty Pharma Summit to be held...


Sep 20, 2017, 07:00 ET Intec Pharma to Participate in the Ladenburg Thalmann 2017 Healthcare Conference

Intec Pharma Ltd. (NASDAQ and TASE: NTEC) today announced that management will participate in the Ladenburg Thalmann 2017 Healthcare Conference to...


Sep 08, 2017, 10:38 ET Intec Pharma to Participate in the 19th Annual Rodman & Renshaw Global Investment Conference

Intec Pharma Ltd. (NASDAQ and TASE: NTEC) today announced that management will participate in the 19th Annual Rodman & Renshaw Global...


Sep 01, 2017, 08:00 ET Intec Pharma to Participate in BioCentury's 24th Annual NewsMakers in the Biotech Industry Conference

Intec Pharma Ltd. (NASDAQ and TASE: NTEC) today announced that management will participate in BioCentury's 24th Annual NewsMakers in the Biotech...


Aug 21, 2017, 16:15 ET Intec Pharma Announces Closing of $57.5 Million Public Offering of Ordinary Shares

Intec Pharma Ltd. (NASDAQ and TASE: NTEC) today announced the closing of its previously announced offering of approximately 12.2 million of its...


Aug 16, 2017, 09:00 ET Intec Pharma Announces Pricing of $50.0 Million Public Offering of Ordinary Shares

Intec Pharma Ltd. (NASDAQ and TASE: NTEC) today announced the pricing of an underwritten public offering of approximately 10.6 million of its...


Aug 15, 2017, 16:01 ET Intec Pharma Announces Proposed Public Offering of Ordinary Shares

Intec Pharma Ltd. (NASDAQ: NTEC) (TASE: NTEC) today announced the launch of an underwritten public offering of its ordinary shares. In connection...


Aug 09, 2017, 17:00 ET Intec Pharma Reports Financial Results for the First Six Months of 2017

Intec Pharma Ltd. (Nasdaq: NTEC) (TASE: NTEC), a clinical-stage biopharmaceutical company focused on developing drugs based on its proprietary...


Aug 03, 2017, 07:00 ET Intec Pharma Reports Clinical Results From Phase I Trial of Accordion Pill for Cannabinoid Therapies

Intec Pharma Ltd. (NASDAQ: NTEC) (TASE: NTEC), a clinical stage biopharmaceutical company focused on developing drugs based on its proprietary...


Jul 27, 2017, 08:00 ET Intec Pharma Promotes Nadav Navon, Ph.D. to Chief Operating Officer

Intec Pharma Ltd. (Nasdaq, TASE: NTEC), a clinical stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion...


Jul 19, 2017, 08:00 ET Intec Pharma Granted Patent in Hong Kong for Accordion Pill™ Carbidopa / Levodopa

Intec Pharma Ltd. (NASDAQ, TASE: NTEC), a clinical-stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion...


Jul 19, 2017, 08:00 ET Intec Pharma Granted Patent in Hong Kong for Accordion Pill™ Carbidopa / Levodopa

Intec Pharma Ltd. (NASDAQ, TASE: NTEC), a clinical-stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion...


Jul 10, 2017, 08:33 ET Intec Pharma Appoints U.S. Life Sciences Executive and Vice Chairman Jeffrey A. Meckler as Chief Executive Officer

Intec Pharma Ltd. (Nasdaq: NTEC, TASE: NTEC), a clinical stage biopharmaceutical company focused on developing drugs based on its proprietary...


May 24, 2017, 08:30 ET Intec Pharma Granted U.S. Patent for Accordion Pill™ Comprising Levodopa for Improved Treatment of Parkinson's Diseases Symptoms

Intec Pharma Ltd. (Nasdaq: NTEC), a clinical stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill™...


May 03, 2017, 04:00 ET Intec Pharma Announces CEO Change

Intec Pharma Ltd. (Nasdaq: NTEC, TASE: NTEC), a clinical stage biopharmaceutical company focused on developing drugs based on its proprietary...


Apr 09, 2017, 02:15 ET Intec Pharma Appoints U.S. Life Sciences Executive Jeffrey A. Meckler to its Board of Directors as Vice Chairman

Intec Pharma Ltd. (Nasdaq: NTEC), a clinical stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion...


Apr 07, 2017, 08:00 ET Intec Pharma Reports 2016 Fourth Quarter and Full Year Financial Results

Intec Pharma Ltd. (Nasdaq and TASE: NTEC), a clinical-stage biopharmaceutical company focused on developing drugs based on its proprietary...


Mar 29, 2017, 07:30 ET Intec Pharma Provides Update on Phase III ACCORDANCE Study of the Accordion Pill Carbidopa/Levodopa in Parkinson's Disease Patients

Intec Pharma Ltd. (Nasdaq; TASE: NTEC), a clinical-stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion...


Mar 22, 2017, 07:00 ET Intec Pharma Initiates Phase I Trial of Accordion Pill for Cannabinoid Therapies

Expects Phase I Results in the Third Quarter of 2017 Intec Pharma Ltd. (Nasdaq; TASE: NTEC), a clinical stage biopharmaceutical company focused...


Mar 17, 2017, 16:00 ET Intec Pharma to Participate in the Oppenheimer 27th Annual Healthcare Conference

Intec Pharma Ltd. (NASDAQ: NTEC), a late stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill™...